Prognosis of patients with malignant mesothelioma by expression of programmed cell death 1 ligand 1 and mesothelin in a contemporary cohort in Finland

Prognosis of patients with malignant mesothelioma by expression of programmed cell death 1 ligand 1 and mesothelin in a contemporary cohort in Finland

Objectives: We aimed to describe mesothelin (MSLN) and programmed cell death 1 ligand 1 (PD-L1) tumour overexpression amongst patients with malignant mesothelioma (MM), and their associations with survival, amongst a cohort of patients with MM in Finland. Methods: Between 2004 and 2017, 91 adults wi...

Full description

Bibliographic Details
Main Authors: David Vizcaya, Bahman Farahmand, Annette O. Walter, Christoph Kneip, Korinna Jöhrens, Mikko Tukiainen, Arndt A. Schmitz
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Mesothelioma
Prognosis
Biomarkers
Disease progression
Programmed cell death 1 ligand 1
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294220300952

Internet

http://www.sciencedirect.com/science/article/pii/S2468294220300952

Similar Items